Screening of a Saccharomyces cerevisiae nonessential gene deletion collection for altered susceptibility to a killer peptide

New Microbiologica

Volumn 31, Issue 1, 2008, Pages 143-145

  Conti, Stefania ^a   Magliani, Walter ^a   Giovati, Laura ^a   Libri, Irene ^a   Maffei, Domenico Leonardo ^a   Salati, Antonella ^a   Polonelli, Luciano ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Deletion mutants; Killer peptide; Saccharomyces cerevisiae

Indexed keywords

K1 KILLER TOXIN, YEAST; MYCOTOXIN; PEPTIDE; SACCHAROMYCES CEREVISIAE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMISTRY; DRUG EFFECT; GENE DELETION; GENETICS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MUTATION; SACCHAROMYCES CEREVISIAE; SYNTHESIS;

GENE DELETION; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOTOXINS; PEPTIDES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

SACCHAROMYCES CEREVISIAE;

EID: 41049100093     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. ANDERSON J.B., SIRJUSINGH C., PARSONS A.B., BOONE C., WICKENS C., COWEN L.E., KOHN L.M. (2003). Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics. 163, 1287-1298.
2. BRACHMANN C.B., DAVIES A., COST G.J., CAPUTO E., LI J., HIETER P., BOEKE J.D. (1998). Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast. 14, 115-132.
3. CASOLI C., PILOTTI E., PERNO C.F., BALESTRA E., POLVERINI E., CASSONE A., CONTI S., MAGLIANI W., POLONELLI L. (2006). A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication. AIDS. 20, 975-980.
4. CENCI E., BISTONI F., MENCACCI A., PERITO S., MAGLIANI W., CONTI S., POLONELLI L., VECCHIARELLI A. (2004). A synthetic peptide as a novel anticryptococcal agent. Cell. Microbiol. 6, 953-961.
5. FIORI P.L., MATTANA A., DESSÌ D., CONTI S., MAGLIANI W., POLONELLI L. (2006). In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide. J. Antimicrob. Chemother. 57, 891-898.
6. KLIS P.M., MOL P., HELLINGWERF K., BRUL S. (2002). Dynamics of cell wall structure in Saccharomyces cerevisiae. FEMS Microbiol. Rev. 26, 239-256.
7. LESAGE G., SDICU A.M., MENARD P., SHAPIRO J., HUSSEIN S., BUSSEY H. (2004). Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin. Genetics. 167, 35-49.
8. MAGLIANI W., CONTI S., GERLONI M., BERTOLOTTI D., POLONELLI L. (1997). Yeast killer systems. Clin. Microbiol Rev. 10, 369-400.
9. MANFREDI M., MCCULLOUGH M.J., CONTI S., POLONELLI L., VESCOVI P., AL KARAAWI Z.M., PORTER S.R. (2005). In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals. Oral Microbiol. Immunol. 20, 226-232.
10. MARKOVICH S., YEKUTIEL A., SHALIT I., SHADKCHAN Y., OSHEROV N. (2004). Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48, 3871-3876.
11. POLONELLI L., MAGLIANI W., CONTI S., BRACCI L., LOZZI L., NERI P., ADRIANI D., DE BERNARDIS F., CASSONE A. (2003). Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect. Immun. 71, 6205-6212.
12. SAVOIA D., SCUTERA S., RAIMONDO S., CONTI S., MAGLIANI W., POLONELLI L. (2006). Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. Exp. Parasitol. 113, 186-192.
13. TRAVASSOS L.R., SILVA L.S., RODRIGUES E.G., CONTI S., SALATI A., MAGLIANI W., POLONELLI L. (2004). Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis. J. Antimicrob. Chemother. 54, 956-958.